These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 23481121)

  • 1. Hyperresistinemia is associated with postmenopausal breast cancer.
    Dalamaga M; Karmaniolas K; Papadavid E; Pelekanos N; Sotiropoulos G; Lekka A
    Menopause; 2013 Aug; 20(8):845-51. PubMed ID: 23481121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated serum visfatin/nicotinamide phosphoribosyl-transferase levels are associated with risk of postmenopausal breast cancer independently from adiponectin, leptin, and anthropometric and metabolic parameters.
    Dalamaga M; Karmaniolas K; Papadavid E; Pelekanos N; Sotiropoulos G; Lekka A
    Menopause; 2011 Nov; 18(11):1198-204. PubMed ID: 21712732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum resistin: a biomarker of breast cancer in postmenopausal women? Association with clinicopathological characteristics, tumor markers, inflammatory and metabolic parameters.
    Dalamaga M; Sotiropoulos G; Karmaniolas K; Pelekanos N; Papadavid E; Lekka A
    Clin Biochem; 2013 May; 46(7-8):584-90. PubMed ID: 23321342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating Adipokines and Inflammatory Markers and Postmenopausal Breast Cancer Risk.
    Gunter MJ; Wang T; Cushman M; Xue X; Wassertheil-Smoller S; Strickler HD; Rohan TE; Manson JE; McTiernan A; Kaplan RC; Scherer PE; Chlebowski RT; Snetselaar L; Wang D; Ho GY
    J Natl Cancer Inst; 2015 Sep; 107(9):. PubMed ID: 26185195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adipocytokine resistin and breast cancer risk.
    Sun CA; Wu MH; Chu CH; Chou YC; Hsu GC; Yang T; Chou WY; Yu CP; Yu JC
    Breast Cancer Res Treat; 2010 Oct; 123(3):869-76. PubMed ID: 20177966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of insulin resistance in patients with obesity: a pilot study.
    Stepien M; Stepien A; Wlazel RN; Paradowski M; Rizzo M; Banach M; Rysz J
    Angiology; 2014 Jan; 65(1):22-30. PubMed ID: 23267236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin resistance in postmenopausal women with metabolic syndrome and the measurements of adiponectin, leptin, resistin, and ghrelin.
    Chu MC; Cosper P; Orio F; Carmina E; Lobo RA
    Am J Obstet Gynecol; 2006 Jan; 194(1):100-4. PubMed ID: 16389017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between estrogens and serum adipocytokines in premenopausal and postmenopausal women.
    Hong SC; Yoo SW; Cho GJ; Kim T; Hur JY; Park YK; Lee KW; Kim SH
    Menopause; 2007; 14(5):835-40. PubMed ID: 17667144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adipohormones as prognostric markers in patients with nonalcoholic steatohepatitis (NASH).
    Krawczyk K; Szczesniak P; Kumor A; Jasinska A; Omulecka A; Pietruczuk M; Orszulak-Michalak D; Sporny S; Malecka-Panas E
    J Physiol Pharmacol; 2009 Oct; 60 Suppl 3():71-5. PubMed ID: 19996485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Could serum visfatin be a potential biomarker for postmenopausal breast cancer?
    Dalamaga M; Archondakis S; Sotiropoulos G; Karmaniolas K; Pelekanos N; Papadavid E; Lekka A
    Maturitas; 2012 Mar; 71(3):301-8. PubMed ID: 22261365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of diagnostic and predictive value of serum adipokines: Leptin, resistin and visfatin in postmenopausal breast cancer.
    Assiri AM; Kamel HF
    Obes Res Clin Pract; 2016; 10(4):442-53. PubMed ID: 26388139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adipocytokines and breast cancer risk.
    Hou WK; Xu YX; Yu T; Zhang L; Zhang WW; Fu CL; Sun Y; Wu Q; Chen L
    Chin Med J (Engl); 2007 Sep; 120(18):1592-6. PubMed ID: 17908478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Visceral fat resection in humans: effect on insulin sensitivity, beta-cell function, adipokines, and inflammatory markers.
    Lima MM; Pareja JC; Alegre SM; Geloneze SR; Kahn SE; Astiarraga BD; Chaim ÉA; Baracat J; Geloneze B
    Obesity (Silver Spring); 2013 Mar; 21(3):E182-9. PubMed ID: 23404948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of 90-day hypolipidemic treatment on insulin resistance, adipokines and proinflammatory cytokines in patients with mixed hyperlipidemia and impaired fasting glucose.
    Buldak L; Dulawa-Buldak A; Labuzek K; Okopien B
    Int J Clin Pharmacol Ther; 2012 Nov; 50(11):805-13. PubMed ID: 22943927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dietary glycemic index/load and peripheral adipokines and inflammatory markers in elderly subjects at high cardiovascular risk.
    Bulló M; Casas R; Portillo MP; Basora J; Estruch R; García-Arellano A; Lasa A; Juanola-Falgarona M; Arós F; Salas-Salvadó J
    Nutr Metab Cardiovasc Dis; 2013 May; 23(5):443-50. PubMed ID: 22209741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nicotinamide phosphoribosyl-transferase/visfatin: a missing link between overweight/obesity and postmenopausal breast cancer? Potential preventive and therapeutic perspectives and challenges.
    Dalamaga M
    Med Hypotheses; 2012 Nov; 79(5):617-21. PubMed ID: 22922056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum levels of adipocytokines in psoriasis patients receiving tumor necrosis factor-α inhibitors: results of a retrospective analysis.
    Campanati A; Ganzetti G; Giuliodori K; Marra M; Bonfigli A; Testa R; Offidani A
    Int J Dermatol; 2015 Jul; 54(7):839-45. PubMed ID: 25877149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adipocyte fatty acid-binding protein as a novel prognostic factor in obese breast cancer patients.
    Hancke K; Grubeck D; Hauser N; Kreienberg R; Weiss JM
    Breast Cancer Res Treat; 2010 Jan; 119(2):367-7. PubMed ID: 19842034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum leptin, resistin, and lipid levels in patients with end stage renal failure with regard to dialysis modality.
    Taskapan MC; Taskapan H; Sahin I; Keskin L; Atmaca H; Ozyalin F
    Ren Fail; 2007; 29(2):147-54. PubMed ID: 17365928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low circulating adiponectin and resistin, but not leptin, levels are associated with multiple myeloma risk: a case-control study.
    Dalamaga M; Karmaniolas K; Panagiotou A; Hsi A; Chamberland J; Dimas C; Lekka A; Mantzoros CS
    Cancer Causes Control; 2009 Mar; 20(2):193-9. PubMed ID: 18814045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.